We are live on
!
Find out more
Eli Lilly
4,350 hedge funds and large institutions have $714B invested in Eli Lilly in 2026 Q1 according to their latest regulatory filings, with 236 funds opening new positions, 1,934 increasing their positions, 1,696 reducing their positions, and 229 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $848B → $714B (-$134B)
23% less funds holding in top 10
Funds holding in top 10: 488 → 376 (-112)
29% less call options, than puts
Call options by funds: $9.52B | Put options by funds: $13.4B
Holders
4,350
Holding in Top 10
376
Calls
$9.52B
Puts
$13.4B
Top Buyers
| 1 | +$1.52B | |
| 2 | +$1.23B | |
| 3 | +$1.08B | |
| 4 |
JP Morgan Chase
New York
|
+$710M |
| 5 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$647M |
Top Sellers
| 1 | -$4.1B | |
| 2 | -$3.8B | |
| 3 | -$1.74B | |
| 4 |
Corient Private Wealth
Miami,
Florida
|
-$1.5B |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$931M |
